gilly6993 said:
aromasin or letrozole....
I agree. I am an aromasin fan over arimidex. Letro is a bit different.
While no ones has asked yet, tamoxifen (i.e. Nolva) will lower IGF-1 levels considerably, thus, it is probably not the best choice unless you really need it, i.e. gyno symptoms.
Arimidex is non-suicidal, which means that a high enough level of androgens will displace it from the receptor sites. This makes it great for low to moderate dose cycles, but ill suited for moderately high and high dose cycles. It does have a long half life, so EOD administration usually is very effective. It is commonly dosed at about 1mg EOD for every 500mgs per week of aromatizable androgens the user is taking. The downside is that it will also lower IGF-1, not as severely as Nolva, but a noticable little bit. A decent choice for lower dose cycles for those on a budget, thought it has been used successfully by many for just about any cycle.
Letrozole (i.e. Femara) is a newer (improved?) version of arimidex, with the primary difference being a shorter half-life which necessitates ED dosages. The big advantage with this one is that it supposedly will not lower IGF-1 levels. The common dose usually runs about 2.5mgs ED.
Aromasin, my choice as mentioned above. It is a suicidal aromatase blocker, thus it is not displaced by a high level of androgens as is arimidex. This is the best that i know of, but its very pricey and hard to find. Its effects on IGF-1 levels are less than arimidex, but higher than Letrozole. The primary downside to this one is that the price is usually considerably more. The common dose is usually 25mgs ED, regardless of the amount of androgens that the user is taking. I have found it to be so effective that I have switched to an EOD dosing schedule myself.